Fiala

Peptide library › Skin & cosmetic

Difelikefalin

Also known as Korsuva, Kapruvia

FDA-approved drugSkin & cosmetic

Anti-itch medicine for people on kidney dialysis, given at the end of each dialysis session.

What people use it for

What Difelikefalin does in the body

Activates kappa-opioid receptors on nerves and immune cells outside the brain. It is built so it barely enters the brain, which lowers the risk of the euphoria and dependence seen with other opioids.

Strength of evidence

Strong: two Phase 3 trials (KALM-1 and KALM-2) reduced itch versus placebo.

Look up the evidence

Live searches of official databases. New to the terms? See the glossary.

Reported side effects & risks

Who should avoid it or take extra care

Not a complete list. Check with a doctor or pharmacist about your own health and medicines.

Regulatory status

FDA-approved in 2021. Given in dialysis units.

How it's taken

Route: Injection into the dialysis line, three times a week

How long it lasts (half-life): About 1 day in people on dialysis

Storage

Stored and prepared by the pharmacy or clinic, following the product label.

Latest research & news

Picked automatically from PubMed, ClinicalTrials.gov and the FDA, and updated daily. Early, lab and animal studies often don't carry over to people.

Keep track of Difelikefalin privately

Fiala is a free app for logging doses, tracking vials and setting reminders. No account, and everything you log stays on your phone.

Open Difelikefalin in Fiala How to install
Not medical advice. This page is general education. Talk to a qualified clinician before starting, stopping or changing any treatment.

More in Skin & cosmetic